Case Type: Mergers & Acquisitions

Patrick Industries, Inc. (NASDAQ: PATK) related to its merger with LCI Industries. Upon completion of the proposed transaction, Patrick shareholders will own approximately 52% of the combined company.

LCI Industries (NYSE: LCII) related to its sale to Patrick Industries, Inc. Under the terms of the proposed transaction, LCI shareholders are expected to receive 1.2440 shares of Patrick common stock for each share of LCI common stock.

Iridium Communications Inc. (NASDAQ: IRDM) related to its sale to Rocket Lab Corporation. Under the terms of the proposed transaction, Iridium shareholders are expected to receive $27.00 in cash and a number of shares of Rocket Lab common stock calculated pursuant to an exchange ratio.

Theravance Biopharma, Inc. (NASDAQ: TBPH) related to its sale to Zymeworks Inc. Under the terms of the proposed transaction, Theravance shareholders are expected to receive (i) $176.00 per share in cash and (ii) one contingent value right.

ENDRA Life Sciences Inc. (NASDAQ: NDRA) related to its merger with Noble Africa LLC. Upon closing of the proposed transaction, ENDRA shareholders are expected to own approximately 3% of the combined company.

Bio-Techne Corporation (NASDAQ: TECH) related to its sale to Merck KGaA. Under the terms of the proposed transaction, Bio-Techne shareholders are expected to receive $73.00 per share in cash.

Synaptics Incorporated (NASDAQ: SYNA) related to its sale to onsemi. Under the terms of the proposed transaction, Synaptics shareholders will receive 1.350 shares of onsemi’s common stock for each Synaptics share.

First Reliance Bancshares, Inc. (OTCQX: FSRL) related to its sale to Colony Bankshares, Inc. Under the terms of the proposed transaction, First Reliance shareholders will receive either (i) $19.75 in cash or 0.94 of a share of Colony’s common stock in exchange for each share of First Reliance common stock.

Colony Bankcorp, Inc. (NYSE: CBAN) related to its merger with First Reliance Bancshares, Inc. Under the terms of the proposed transaction, First Reliance shareholders will receive either (i) $19.75 in cash or 0.94 of a share of Colony’s common stock in exchange for each share of First Reliance common stock.

Selectis Health, Inc. (OTCMKTS: GBCS) related to its sale to Black Pearl Equities II, LLC. Under the terms of the proposed transaction, Selectis Health shareholders will receive $5.75 per share in cash.